As filed with the Securities and Exchange Commission on May 6, 2024. Registration Number 333-279122 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________ SAFE AND GREEN DEVELOPMENT CORPORATION (Exact Name of Registrant as Specified in its Charter) ______________________________________________ | Delaware | 6552 | 87-1375590 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporati ...

As filed with the Securities and Exchange Commission on May 1, 2024 Registration No. 333-278358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 AMENDMENT NO. 1 TO Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 WEARABLE DEVICES LTD. (Exact name of registrant as specified in its charter) | State of Israel | 3873 | Not Applicable | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | ...

费用与认购 - 公司预计发行和分销其他费用总计100万美元[9] - 2023年12月18日，发起人以2.5万美元收购718.75万股创始人股份，约每股0.003美元[13] - 公司发起人认购65万份私募单位，总购买价650万美元，若超额配售权全行使最多725万美元[15] 公司性质与修订 - 公司是非加速申报公司、较小报告公司和新兴成长公司[5] - 本次修订仅为向注册声明提交一份附件[7] 责任与赔偿 - 公司将为董高提供法律允许最大程度赔偿，购买董高责任险[10] - 董高同意放弃对信托账户资金权利和索赔（除非因持有公开发行股份有权获资金）[11] - SEC认为《证券法》下赔偿违反公共政策，无法执行[12] - 若董高或控制人提出赔偿索赔，公司将提交法院裁决[20] - 公司承诺为确定《证券法》下责任，某些信息视为注册声明一部分[20]

费用与投资数据 - 公司预计发行和分销其他费用总计100万美元，含多项明细[9] - 2023年12月18日发起人2.5万美元收购718.75万股创始人股份，约每股0.003美元，预计占发行后流通股20%[13] - 发起人认购65万份私募单位，总价650万美元，最多725万美元，每份私募认股权证可按11.5美元/股买一股A类普通股[15] 公司性质与文件 - 公司被认定为非加速申报公司、较小报告公司和新兴成长公司[5] - 本次修订仅为向注册声明提交一份附件[7] - 修订后的注册声明于2024年5月1日由CEO和CFO签署[24] 赔偿与保险 - 公司将为董事和高管提供赔偿并预计买责任险[10] - 董事和高管同意放弃对信托账户资金权利和索赔，赔偿有条件支付[11] - SEC认为相关赔偿违反公共政策不可执行，公司承诺提交法院裁定[12][20]

As filed with the U.S. Securities and Exchange Commission on May 1, 2024. Registration No. 333-278076 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to FORM S-1 10 Times Square, 30 Floor New York, New York 10018 (212) 634-9206 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) James Walker Chief Executive Officer Nano Nuclear Energy Inc. 10 Times Square, 30 Floor New York, New York 10018 (212) 634-920 ...

As filed with the U.S. Securities and Exchange Commission on April 29, 2024. Registration No. 333-278076 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 4911 88-0861977 (I.R.S. Employer Identification No.) 10 Times Square, 30 Floor New York, New York 10018 (212) 634-9206 (Addr ...

文件提交 - 公司于2024年4月26日向美国证券交易委员会提交文件，注册编号为333 - 275197[1] - 此次提交的是2023年10月27日原注册声明的第6次修订案[7] - 公司于2024年4月26日在香港认证符合Form F - 1的所有申报要求并签署注册声明[28] 章程与股份 - 2023年5月10日起生效的修订章程授权公司对董事和高级管理人员的某些责任进行赔偿[9] - 2023年5月10日公司进行股份拆分，1股拆分为160,000股，面值从1美元变为0.00000625美元[13] 证券发行与转让 - 2022年7月24日向Tim Hoi Ching等发行未注册证券，Tim Hoi Ching获90股，支付90美元[12][13] - 2022年9月8日，Tim Hoi Ching向APTC Holdings Limited和Chun Yin Ling各转让5股普通股[13] - 2023年8月30日，Market Tycoon Investments Limited向WONG TAI CHI转让480,000股普通股[14] - 2023年10月11日，WONG TAI CHI向Value Crystal Investment Limited转让480,000股普通股[14] - 2023年10月11日，Value Classic Global Limited向Crystal Charm Investments Limited转让640,000股普通股[15] - 2023年8月30日，APTC Holdings Limited向LOOK Wai Yi转让800,000股普通股，10月11日LOOK Wai Yi向Ace Challenger Limited转让800,000股[16] 人员签署 - 公司首席执行官Tim Hoi Ching于2024年4月26日签署注册声明[31] - 美国授权代表于2024年4月26日在特拉华州纽瓦克签署注册声明[32]

Registration No. 333-278601 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 4677 L B McLeod Rd Suite J Orlando, FL 32811 (855) 921-4600 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive of ices) Allan Evans Chief Executive Officer Unusual Ma ...

Washington, D.C. 20549 As filed with the Securities and Exchange Commission on April 2, 2024. Registration No. 333-276741 UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Allan J. Camaisa Chief Executive Officer c/o Calidi Biotherapeutics, Inc. 4475 Executive Drive, Suite 200, San Diego, CA 92121 Telephone: (858) 794-9600 (Name, address, including zip code, and telephone number, including ar ...

As filed with the Securities and Exchange Commission on April 2, 2024. Registration No. 333-278006 UNITED STATES SECURITIES AND EXCHANGE COMMISSION MUSTANG BIO, INC. Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2836 (Primary Standard Industrial Classification Code Number) Washington, D.C. 20549 47-3828760 (I.R.S. Employer Identification Number) ...